1. Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017
- Author
-
Jacquelyn Njoroge, Jane Neale, Rachel Kwiatkowska, Maggie Telfer, Bruno Pichon, Mathew Hickman, Stephen Thompson, Camillus Buunaaisie, Maya Gobin, Angela Kearns, Isabel Oliver, Owen Martin Williams, Michel Doumith, Simon Packer, Vivian Hope, Noreen Hopewell-Kelly, Ellen Heinsbroek, and Monica Desai
- Subjects
Male ,0301 basic medicine ,Epidemiology ,Intravenous: microbiology ,community acquired infections epidemiology ,Bacteremia ,MRSA ,medicine.disease_cause ,0302 clinical medicine ,RA0421 ,Risk Factors ,Surveys and Questionnaires ,Staphylococcal Infections/transmission ,Prevalence ,Community acquired infections microbiology ,Infection control ,030212 general & internal medicine ,Substance Abuse, Intravenous ,Phylogeny ,Substance-Related Disorders/microbiology ,Molecular Epidemiology ,Intravenous: complications ,Transmission (medicine) ,community acquired infections ,Substance Abuse ,Staphylococcal Infections ,3. Good health ,Community-Acquired Infections ,Substance abuse ,complications [Intravenous] ,whole-genome sequencing ,Staphylococcus aureus ,Drug users ,microbiology [Intravenous] ,Female ,Staphylococcal epidemiology ,Intravenous ,Adult ,Methicillin-Resistant Staphylococcus aureus ,Meticillin-Resistant Staphylococcus aureus ,Community acquired infections epidemiology ,Community acquired infections ,030106 microbiology ,community acquired infections microbiology ,03 medical and health sciences ,Sepsis ,Virology ,Environmental health ,medicine ,Humans ,Retrospective Studies ,Whole-genome sequencing ,Whole Genome Sequencing ,Molecular epidemiology ,business.industry ,Research ,Public Health, Environmental and Occupational Health ,Outbreak ,Sequence Analysis, DNA ,Odds ratio ,medicine.disease ,United Kingdom ,Molecular Typing ,Colonisation ,Cross-Sectional Studies ,Injecting drug use ,business ,staphylococcal epidemiology ,Substance-Related Disorders/complications - Abstract
Background: In 2015, Bristol (South West England) experienced a large increase in cases of meticillin-resistant Staphylococcus aureus (MRSA) infection in people who inject drugs (PWID). Aim: We aimed to characterise and estimate the prevalence of MRSA colonisation among PWID in Bristol and test evidence of a clonal outbreak. Methods: PWID recruited through an unlinked-anonymous community survey during 2016 completed behavioural questionnaires and were screened for MRSA. Univariable logistic regression examined associations with MRSA colonisation. Whole-genome sequencing used lineage-matched MRSA isolates, comparing PWID (screening and retrospective bacteraemia samples from 2012-2017) with non-PWID (Bristol screening) in Bristol and national reference laboratory database samples. Results: The MRSA colonisation prevalence was 8.7% (13/149) and was associated with frequently injecting in public places (odds ratio (OR): 5.5; 95% confidence interval (CI):1.34–22.70), recent healthcare contact (OR: 4.3; 95% CI: 1.34–13.80) and injecting in groups of three or more (OR: 15.8; 95% CI: 2.51–99.28). People reporting any one of: injecting in public places, injection site skin and soft tissue infection or hospital contact accounted for 12/13 MRSA positive cases (sensitivity 92.3%; specificity 51.5%). Phylogenetic analysis identified a dominant clade associated with infection and colonisation among PWID in Bristol belonging to ST5-SCCmecIVg. Conclusions: MRSA colonisation in Bristol PWID is substantially elevated compared with general population estimates and there is evidence of clonal expansion, community-based transmission and increased infection risk related to the colonising strain. Targeted interventions, including community screening and suppression therapy, education and basic infection control are needed to reduce MRSA infections in PWID.
- Published
- 2019
- Full Text
- View/download PDF